We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

68 hedge funds and large institutions have $217M invested in VanEck Biotech ETF in 2014 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

56% more call options, than puts

Call options by funds: $4.07M | Put options by funds: $2.62M

47% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 15

42% more capital invested

Capital invested by funds: $153M → $217M (+$63.6M)

15% more funds holding

Funds holding: 59 → 68 (+9)

6.77% more ownership

Funds ownership: 28.89% → 35.66% (+6.8%)

Holders
68
Holders Change
+9
Holders Change %
+15.25%
% of All Funds
1.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
22
Reduced
15
Closed
8
Calls
$4.07M
Puts
$2.62M
Net Calls
+$1.45M
Net Calls Change
-$2.44M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$37.8M
2
Morgan Stanley
Morgan Stanley
New York
+$11.5M
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$3.36M
4
UCFA
United Capital Financial Advisors
Texas
+$3.31M
5
AP
Advisors Preferred
Maryland
+$2.28M

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$20.3M
2
AFG
Albion Financial Group
Utah
-$1.31M
3
CM
Churchill Management
California
-$814K
4
SG Americas Securities
SG Americas Securities
New York
-$498K
5
Jane Street
Jane Street
New York
-$415K
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
26
SG Americas Securities
New York
$1.65M -$498K -4,420 -24%
WJA
27
Williams Jones & Associates
New York
$1.61M +$104K +925 +7%
KCM
28
Karp Capital Management
California
$1.61M +$1.57M +13,950 New
Bank of America
29
Bank of America
North Carolina
$1.56M -$316K -2,804 -17%
Commonwealth Equity Services
30
Commonwealth Equity Services
Massachusetts
$1.31M -$39.8K -353 -3%
NPC
31
National Planning Corporation
California
$1.22M -$14.9K -132 -1%
NES
32
New England Securities
New York
$986K +$873K +7,744 +969%
NCM
33
Niemann Capital Management
Nevada
$817K +$798K +7,085 New
GJIC
34
Gamble Jones Investment Counsel
California
$692K – – –
Stifel Financial
35
Stifel Financial
Missouri
$692K +$676K +6,000 New
AIG
36
American International Group
New York
$641K +$562K +4,990 +882%
HighTower Advisors
37
HighTower Advisors
Illinois
$533K -$451 -4 -0.1%
PTC
38
Private Trust Company
Ohio
$520K – – –
Cambridge Investment Research Advisors
39
Cambridge Investment Research Advisors
Iowa
$431K +$27.8K +247 +7%
IAMOG
40
Investors Asset Management of Georgia
Georgia
$427K +$417K +3,700 New
Bank of New York Mellon
41
Bank of New York Mellon
New York
$392K – – –
First Manhattan
42
First Manhattan
New York
$346K – – –
Citadel Advisors
43
Citadel Advisors
Florida
$313K +$306K +2,716 New
MFS
44
MSI Financial Services
Massachusetts
$305K +$196K +1,740 +193%
CFMC
45
Curbstone Financial Management Corp
New Hampshire
$301K -$33.8K -300 -10%
ICAS
46
Investors Capital Advisory Services
Massachusetts
$297K +$290K +2,575 New
SC
47
Scotia Capital
Ontario, Canada
$280K – – –
DBIA
48
Dumont & Blake Investment Advisors
New Jersey
$272K – – –
JPTCCM
49
J.P. Turner & Co Capital Management
Georgia
$202K +$197K +1,748 New
SIG
50
Stanford Investment Group
California
$193K +$189K +1,675 New
1
2
3 4

BBH Hedge Fund Activity: Q4 2014 in Review

68 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2014, worth a combined $217M — up 42% from $153M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new BBH positions and 8 closed out — a net gain of 10 holders — while 22 added to existing stakes and 15 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $37.8M. The largest seller was Credit Suisse, cutting an estimated $20.3M.

  • 68 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2014, up from 59 in Q3 2014.
  • Funds reported $217M of VanEck Biotech ETF stock for Q4 2014, up 42% quarter-over-quarter.
  • 18 funds opened new VanEck Biotech ETF positions in Q4 2014 and 8 closed out, a net change of +10 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2014 was Goldman Sachs, an estimated $37.8M added.
  • The largest VanEck Biotech ETF seller in Q4 2014 was Credit Suisse, an estimated $20.3M sold.

Based on aggregated 13F filings for Q4 2014.